254 related articles for article (PubMed ID: 28489583)
1. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.
Tang J; Qin Z; Li X; Han P; Wang F; Yang C; Li R; Wang K; Tang M; Wang W; Lv Q; Zhang W
Oncotarget; 2017 Jul; 8(30):50034-50050. PubMed ID: 28489583
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.
Gong M; Dong W; Shi Z; Qiu S; Yuan R
Oncotarget; 2017 Jan; 8(5):8447-8458. PubMed ID: 28039484
[TBL] [Abstract][Full Text] [Related]
3. Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis.
Yang F; Qin Z; Shao C; Liu W; Ma L; Shu Y; Shen H
Biomed Res Int; 2018; 2018():9271215. PubMed ID: 30013987
[TBL] [Abstract][Full Text] [Related]
4. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
5. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG
Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357
[TBL] [Abstract][Full Text] [Related]
6. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
[TBL] [Abstract][Full Text] [Related]
7. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.
Yang YQ; Chen J
Genet Mol Res; 2014 Jul; 13(3):5011-7. PubMed ID: 25062489
[TBL] [Abstract][Full Text] [Related]
8. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects.
Song Y; Hu J; Chen Q; Guo J; Zou Y; Zhang W; Chen X; Hu W; Huang P
Gene; 2018 Dec; 679():241-252. PubMed ID: 30195633
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
Xian W; Zheng H; Wu WJ
Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
[TBL] [Abstract][Full Text] [Related]
10. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
Zhong W; Wang X; Pan B; Su Z
Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis.
Cheng D; Hao Y; Zhou W; Ma Y
PLoS One; 2013; 8(11):e78173. PubMed ID: 24223772
[TBL] [Abstract][Full Text] [Related]
12. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
Shen BL; Qu QS; Miao SZ; Zhang YX
Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis.
Zhang Y; Yu YF; Wang JZ; Jia H
Genet Mol Res; 2015 Aug; 14(3):8909-18. PubMed ID: 26345822
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor gene polymorphisms and gastric cancer risk: a meta-analysis.
Zhuang M; Peng Z; Wang J; Su X
J BUON; 2017; 22(3):714-724. PubMed ID: 28730780
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.
Lu G; Dong Y; Zhang Q; Jiao L; Yang S; Shen B
Tumour Biol; 2015 Nov; 36(11):8645-52. PubMed ID: 26044558
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the glutathione S-transferase genes polymorphisms in the risk and prognosis of renal cell carcinomas. Case-control and meta-analysis.
Abid A; Ajaz S; Khan AR; Zehra F; Hasan AS; Sultan G; Mohsin R; Hashmi A; Niamatullah N; Rizvi SA; Mehdi SQ; Khaliq S
Urol Oncol; 2016 Sep; 34(9):419.e1-419.e12. PubMed ID: 27185341
[TBL] [Abstract][Full Text] [Related]
18. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
Sáenz-López P; Vazquez F; Cozar JM; Carretero R; Garrido F; Ruiz-Cabello F
Hum Immunol; 2013 Jan; 74(1):98-103. PubMed ID: 23073296
[TBL] [Abstract][Full Text] [Related]
19. Three Polymorphisms of Vascular Endothelial Growth Factor (+936C > T, -460C > T, and -2578C > A) and Their Susceptibility to Ovarian Cancer: A Meta-Analysis.
Zhang X; Qin J; Qin A
Int J Gynecol Cancer; 2015 Jun; 25(5):779-85. PubMed ID: 25835351
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor polymorphisms and risk of Alzheimer's disease: a meta-analysis.
He D; Lu W; Chang K; Liu Y; Zhang J; Zeng Z
Gene; 2013 Apr; 518(2):296-302. PubMed ID: 23370341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
